Alles Institute For Medical Research is located in El Cerrito, CA. The organization was established in 2016. According to its NTEE Classification (H90) the organization is classified as: Medical Disciplines Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Alles Institute For Medical Research is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Alles Institute For Medical Research generated $1.2m in total revenue. This represents relatively stable growth, over the past 4 years the organization has increased revenue by an average of 2.9% each year. All expenses for the organization totaled $268.9k during the year ending 12/2022. While expenses have increased by 3.5% per year over the past 4 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
BASIC AND APPLIED RESEARCH INTO THE CAUSES AND POTENTIAL TREATMENTS FOR A VARIETY OF HUMAN DISORDERS, INCLUDING TYPE 1 DIABETES. SUPPORT FOR THE DEVELOPMENT OF ADVANCED TECHNOLOGIES TO IMPROVE THE DISCOVERY PROCESS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
ALLES INSTITUTE FOR MEDICAL RESEARCH CONTINUED ITS COLLABORATIVE RESEARCH PROJECT AT MASSACHUSETTS GENERAL HOSPITAL IN 2020. THE RESEARCHER IS EXPLORING A QUANTITATIVE PCR METHOD TO TEST THE GENETIC EXPRESSION OF T-REGULATORY CELLS. PCR IS A TECHNIQUE USED TO AMPLIFY DNA TO GENERATE MILLIONS OF COPIES OF A PARTICULAR DNA SEQUENCE. THROUGH SIDE-BY-SIDE COMPARISON OF PCR AND FLOW CYTOMETRY METHODS, SHE WILL BE ABLE TO TRACK THE ACCURACY OF PCR RESULTS. THE FINDINGS OF THIS RESEARCH MAY PROVIDE A NEW, ACCURATE, AND MORE EFFECTIVE TECHNIQUE FOR TRACKING T-REGULATORY CELLS IN TYPE 1 DIABETES AND OTHER AUTOIMMUNE RESEARCH.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Julia Schwartz Secretary | OfficerTrustee | 1 | $1,058 |
Alice Schwartz President | OfficerTrustee | 1 | $0 |
Norman Schwartz Treasurer | OfficerTrustee | 1 | $0 |
Allison Schwartz Director | Trustee | 0 | $0 |
Adria Schwartz Director | Trustee | 0 | $0 |
Steven Schwartz Director | Trustee | 0 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $1,076,870 |
Noncash contributions included in lines 1a–1f | $1,076,870 |
Total Revenue from Contributions, Gifts, Grants & Similar | $1,076,870 |
Total Program Service Revenue | $0 |
Investment income | $61 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $82,728 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,159,659 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $67,000 |
Pension plan accruals and contributions | $4,020 |
Other employee benefits | $10,334 |
Payroll taxes | $6,554 |
Fees for services: Management | $1,058 |
Fees for services: Legal | $1,443 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $12,058 |
Advertising and promotion | $508 |
Office expenses | $0 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $0 |
Total functional expenses | $268,890 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $7,355 |
Savings and temporary cash investments | $76,697 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $5,586,223 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $5,670,275 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $5,670,275 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $5,670,275 |